ASCENDIS HEALTH LIMITED - Dealings in securities by directors

Dealings in securities by directors

ASCENDIS HEALTH LIMITED
(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
(“Ascendis”)

Dealings in securities by directors

In terms of paragraphs 3.63 to 3.74 of the JSE Listings Requirements, the following information,
relating to dealings in securities by directors, is disclosed:


Directors:                            Gary Shayne and Crispian Dillon.

Nature of the transaction:            Coast2Coast Capital Proprietary Limited (“C2C”) (in
                                      which Gary Shayne holds an 85% indirect interest and
                                      Crispian Dillon holds a 15% indirect interest), is
                                      required to redeem an existing debenture issued by
                                      an indirect subsidiary of C2C by way of a settlement of
                                      Ascendis shares. The Ascendis shares are thus
                                      transferred to effect the redemption of the debenture
                                      at a pre-determined discount to the 30 day volume
                                      weighted average price at 1 July 2016 of R23.78. The
                                      discount was applied to achieve an agreed return on
                                      the debenture and therefore should not be used to
                                      evaluate a fair share price for Ascendis in the open
                                      market.

Number of shares:                     1,401,975

Price per share:                      R21.3984

Value:                                R30,000,000

Date of transaction:                  27 October 2016

Class of shares:                      Ordinary shares

Nature of transaction:                Sale, off market

Extent of interest:                   Indirect beneficial (through C2C, in which Gary
                                      Shayne has an 85% indirect beneficial interest and
                                      Crispian Dillon has a 15% indirect beneficial interest).

Written clearance obtained:           Clearance was obtained from the Chairman.



1 November 2016
Johannesburg

Sponsor
Investec Bank Limited

Date: 01/11/2016 08:30:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.